ABO-incompatible heart transplantation: An alternative to improve the donor shortage in infants

Current Opinion in Organ Transplantation

Volumn 10, Issue 4, 2005, Pages 364-368

  West, Lori J ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

ABO incompatible; Cardiac transplant; Infant; Tolerance

Indexed keywords

ANTIBODY DETECTION; B LYMPHOCYTE; BLOOD GROUP ABO INCOMPATIBILITY; HEART TRANSPLANTATION; HUMAN; NONHUMAN; REVIEW; TREATMENT OUTCOME; XENOTRANSPLANTATION;

EID: 28044441080     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/01.mot.0000188316.19534.3c     Document Type: Review

References (64)

1. Boucek MM, Edwards LB, Keck BM, et al. Registry of the International Society for Heart and Lung Transplantation: eighth official pediatric report 2005. J Heart Lung Transplant 2005; 24:968-982. This is the latest report of paediatric heart transplantation activity from the international registry.
2. Boucek MM, Edwards LB, Keck BM, et al. Registry for the International Society for Heart and Lung Transplantation: seventh official pediatric report 2004. J Heart Lung Transplant 2004; 23:933-947.
3. Utterson EC, Shepherd RW, Sokol RJ, et al. Biliary atresia: clinical profiles, risk factors, and outcomes of 755 patients listed for liver transplantation. J Pediatr 2005; 147:180-185. This article describes the use of lobar transplants for paediatric liver transplantation.
4. Kasahara M, Ueda M, Haga H, et al. Living-donor liver transplantation for hepatoblastoma. Am J Transplant 2005; 5:2229-2235. This article describes living-donor transplantation for paediatric liver transplants, in which partial organ transplantation is performed.
5. Barshes NR, Lee TC, Udell IW, et al. Adult liver transplant candidate attitudes toward graft sharing are not obstacles to split liver transplantation. Am J Transplant 2005; 5:2047-2051.
6. Lee TC, Barshes NR, Washburn WK, et al. Split-liver transplantation using the left lateral segment: a collaborative sharing experience between two distant centers. Am J Transplant 2005; 5:1646-1651. This paper confirms the success of liver graft sharing for paediatric patients.
7. McDonald RA, Smith JM, Stablein D, Harmon WE. Pretransplant peritoneal dialysis and graft thrombosis following pediatric kidney transplantation: a NAPRTCS report. Pediatr Transplant 2003; 7:204-208.
8. Seikaly M, Ho PL, Emmett L, Tejani A. The 12th annual report of the North American Pediatric Renal Transplant Cooperative Study: renal transplantation from 1987 through 1998. Pediatr Transplant 2001; 5:215-231.
9. Benfield MR, McDonald R, Sullivan EK, et al. The 1997 annual renal transplantation in children report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1999; 3:152-167.
10. Chrisant MR, Naftel DC, Drummond-Webb J, et al. Fate of infants with hypoplastic left heart syndrome listed for cardiac transplantation: a multicenter study. J Heart Lung Transplant 2005; 24:576-582. This paper provides comprehensive multicentre data from the Pediatric Heart Transplant Study on infants listed for heart transplantation for hypoplastic left-sided heart syndrome.
11. Fukushima N, Gundry SR, Razzouk AJ, Bailey LL. Growth of oversized grafts in neonatal heart transplantation. Ann Thorac Surg 1995; 60:1659-1663.
12. Dellgren G, Koirala B, Sakopoulus A, et al. Pediatric heart transplantation: improving results in high-risk patients. J Thorac Cardiovasc Surg 2001; 121:782-791.
13. Starzl T, Ishikawa M, Putnam C, et al. Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc 1974;6:129.
14. Paul L, Baldwin WM3rd. Humoral rejection mechanisms and ABO incompatibility in renal transplantation. Transplant Proc 1987; 19:4463.
15. Alexandre G, Squifflet J, De Bruyere M, et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987; 19:4538.
16. Wu A, Buhler LH, Cooper DK. ABO-incompatible organ and bone marrow transplantation: current status. Transpl Int 2003; 16:291-299.
17. Dean PG, Gloor JM, Stegall MD. Conquering absolute contraindications to transplantation: positive-crossmatch and ABO-incompatible kidney transplantation. Surgery 2005; 137:269-273. Describes new protocols that have been developed for ABO-incompatible kidney transplantation. Also addresses maneuvers for kidney transplantation in HLA-sensitized patients.
18. Tyden G, Kumlien G, Genberg H, et al. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 2005; 5:145-148. Describes new protocols that have been developed for ABO-incompatible kidney transplantation.
19. Sonnenday CJ, Warren DS, Cooper M, et al. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 2004; 4:1315-1322. Describes new protocols that have been developed for ABO-incompatible kidney transplantation.
20. Warren DS, Zachary AA, Sonnenday CJ, et al. Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers. Am J Transplant 2004; 4:561-568. Describes new protocols that have been developed for ABO-incompatible kidney transplantation. Also addresses maneuvers for kidney transplantation in HLA-sensitized patients.
21. Shishido S, Hasegawa A. Current status of ABO-incompatible kidney transplantation in children. Pediatr Transplant 2005; 9:148-154. This article specifically addresses evolving strategies for ABO-incompatible kidney transplantation in paediatric patients.
22. King KE, Warren DS, Samaniego-Picota M, et al. Antibody, complement and accommodation in ABO-incompatible transplants. Curr Opin Immunol 2004; 16:545-549. This is a review of the immunologic sequelae in ABO-incompatible transplants undertaken with new strategies for management of antibody and B cells.
23. Montgomery RA, Hardy MA, Jordan SC, et al. Consensus opinion from the Antibody Working Group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols. Transplantation 2004; 78:181-185. This is a consensus document on the new management strategies for renal transplantation in patients with ABO-directed or HLA-directed antibodies.
24. Takemoto SK, Zeevi A, Feng S, et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004; 4: 1033-1041. This is a report from a national conference on antibody-mediated rejection in solid organ transplantation, undertaken upon review of new strategies to manage antibodies and B cells.
25. Squifflet JP, De Meyer M, Malaise J, et al. Related lessons learned from ABO-incompatible living donor kidney transplantation: 20 years later. Exp Clin Transplant 2004; 2:208-213. This article by authors who were active in the field 20 years ago revisits the early experience of ABO-incompatible renal transplantation in light of new developments in the management of antibody-mediated rejection.
26. Kozaki K, Egawa H, Kasahara M, et al. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation. Ther Apher Dial 2005; 9:285-291. Data are presented in this article on evolving strategies to manage ABO-incompatible liver transplants in Japan, where deceased donors are exceedingly rare.
27. Yoshizawa A, Sakamoto S, Ogawa K, et al. New protocol of immunosuppression for liver transplantation across ABO barrier: the use of Rituximab, hepatic arterial infusion, and preservation of spleen. Transplant Proc 2005; 37:1718-1719. This paper document new protocols for liver transplantation across ABO incompatibility from the Japanese groups, particularly the use of rituximab.
28. Usuda M, Fujimori K, Koyamada N, et al. Successful use of anti-CD20 monoclonal antibody (rituximab) for ABO-incompatible living-related liver transplantation. Transplantation 2005; 79:12-16. This paper documents new protocols for liver transplantation across ABO incompatibility from the Japanese groups, particularly the use of rituximab.
29. Cooper DK. Clinical survey of heart transplantation between ABO blood group-incompatible recipients and donors. J Heart Transplant 1990; 9:376-381.
30. Caruana RJ, Zumbro GL Jr, Hoff RG, et al. Successful cardiac transplantation across an ABO blood group barrier. Transplantation 1988; 46:472-474.
31. Pikul FJ, Bolman RM, Saffitz JE, Chaplin H. Anti-B-mediated rejection of an ABO-incompatible cardiac allograft despite aggressive plasma exchange transfusion. Transplant Proc 1987; 19:4601-4604.
32. Albrechtsen D, Geiran O, Foerster A, et al. Cardiac transplantation from a blood group ABO-incompatible donor: a case report. Transplant Proc 1990; 22:143.
33. Ott GY, Norman D, Ratkovec RR, et al. ABO-incompatible heart transplantation: a special case for the A2 donor. J Heart Lung Transplant 1993; 12:504-507.
34. Mohacsi P, Rieben R, Sigurdsson G, et al. Successful management of a B-type cardiac allograft into an O-type man with 3(1/2)-year clinical follow-up. Transplantation 2001; 72:1328-1330.
35. Banner NR, Rose ML, Cummins D, et al. Management of an ABO-incompatible lung transplant. Am J Transplant 2004; 4:1192-1196.
36. Terasaki PI. ABO mismatching errors in heart transplants. Lancet 2003; 362:332.
37. Campion EW. A death at Duke. N Engl J Med 2003; 348:1083-1084.
38. West LJ. Defining critical windows in the development of the human immune system. Hum Exp Toxicol 2002; 21:499-505.
39. Wilson CB. Immunologic basis for increased susceptibility of the neonate to infection. J Pediatr 1986; 108:1-12.
40. Cadoz M. Potential and limitations of polysaccharide vaccines in infancy. Vaccine 1998; 16:1391-1395.
41. Fong SW, Qaqundah BY, Taylor WF. Developmental patterns of ABO isoagglutinins in normal children correlated with the effects of age, sex and maternal isoagglutinins. Transfusion 1974; 14:551-559.
42. Springer GF, Horton RE. Blood group isoantibody stimulation in man by feeding blood group-active bacteria. J Clin Invest 1969; 48:1280-1291.
43. West LJ, Pollock-Barziv SM, Dipchand AI, et al. ABO-incompatible heart transplantation in infants. N Engl J Med 2001; 344:793-800.
44. Foreman C, Gruenwald C, West L. ABO-incompatible heart transplantation: a perfusion strategy. Perfusion 2004; 19:69-72. This article presents a detailed guide for the perfusion team for plasma exchange during cardiopulmonary bypass during ABO-incompatible heart transplantation.
45. Rao JN, Hasan A, Hamilton JR, et al. ABO-incompatible heart transplantation in infants: the Freeman Hospital experience. Transplantation 2004; 77:1389-1394. The experience from the UK team in Newcastle with ABO-incompatible infant heart transplantation, based on the experience of the Toronto group, is presented in this article.
46. Rodriguez RJ, Addonizio LJ, Lamour JM, et al. Pediatric heart transplantation across ABO blood type barriers: a case study. Prog Transplant 2005; 15:161-165. This case report documents one of the early cases of ABO-incompatible infant heart transplantation performed in the United States, based on the Toronto protocol.
47. Schmoeckel M, Dabritz S, Kozlik-Feldmann R, et al. Successful ABO-incompatible heart transplantation in two infants. Transpl Int 2005 Oct; 18:1210-1214. This case report documents two recent cases of ABO-incompatible infant heart transplantation performed in Germany, based on the Toronto protocol.
48. West LJ, Pollock-BarZiv SM, Ang A, et al. Outcomes of the world experience in ABO-incompatible infant heart transplantation. Am J Transplant 2005; 5:157. This report was presented at the 2005 annual meetings of the American Transplant Congress. It documents the outcomes of the global experience of ABO-incompatible infant heart transplantation from the ABOi International Collaborative Group.
49. Chopek MW, Simmons RL, Platt JL. ABO-incompatible kidney transplantation: initial immunopathologic evaluation. Transplant Proc 1987; 19:4553-4557.
50. Platt JL, Bach FH. The barrier to xenotransplantation. Transplantation 1991; 52:937-947.
51. Koch CA, Khalpey ZI, Platt JL. Accommodation: preventing injury in transplantation and disease. J Immunol 2004; 172:5143-5148. This article presents an important discussion of the evolving evidence of mechanisms of accommodation.
52. Williams JM, Holzknecht ZE, Plummer TB, et al. Acute vascular rejection and accommodation: divergent outcomes of the humoral response to organ transplantation. Transplantation 2004; 78:1471-1478. This paper examines accommodation and in particular the importance of complement activation.
53. Bach FH. Heme oxygenase-1: a therapeutic amplification funnel. FASEB J 2005; 19:1216-1219. This article continues the work of this author on the emerging importance of heme oxygenase-1 in accommodation and other physiologic pathways.
54. Bach FH, Ferran C, Hechenleitner P, et al. Accommodation of vascularized xenografts: expression of 'protective genes' by donor endothelial cells in a host Th2 cytokine environment. Nat Med 1997; 3:196-204.
55. Sebille F, Dorling A. Tolerance or accommodation: the lesson from leflunomide. Transplantation 2005; 79:133-134. This discussion examines the potential interplay between mechanisms that may ultimately lead to either tolerance or accommodation or both.
56. Chen D, Weber M, McVey JH, et al. Complete inhibition of acute humoral rejection using regulated expression of membrane-tethered anticoagulants on xenograft endothelium. Am J Transplant 2004; 4:1958-1963. This important study elegantly examines the role of coagulation in graft damage vs protection in the presence of antidonor antibody.
57. Takahashi K. A new concept of accommodation in ABO-incompatible kidney transplantation. Clin Transplant 2005; 19(Suppl 14):76-85. This paper discusses evolving concepts of graft accommodation in clinical transplantation.
58. Fan X, Ang A, Pollock-Barziv SM, et al. Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat Med 2004; 10:1227-1233. This paper reports the immunologic development of infants following ABO-incompatible heart transplantation. Its importance lies in the careful delineation of B-cell tolerance in human infants.
59. Koestner SC, Kappeler A, Schaffner T, et al. Histo-blood group type change of the graft from B to O after ABO mismatched heart transplantation. Lancet 2004; 363:1523-1525. This article reports an elegant demonstration of blood group antigens in the graft of an ABO-incompatible heart transplant, and their change over time from donor to recipient blood type.
60. West LJ. Targeting antibody-mediated rejection in the setting of ABO-incompatible infant heart transplantation: graft accommodation vs. B cell tolerance. Curr Drug Targets Cardiovasc Haematol Disord 2005; 5:223-232. This paper offers a discussion of the relative likelihood of tolerance vs accommodation in the setting of antibody to donor antigens.
61. West LJ Developmental aspects of immunomodulation: exploiting the immature immune system for organ transplantation. Transpl Immunol 2002; 9:149-153.
62. Platt JL, Fischel RJ, Matas AJ, et al. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 1991; 52:214-220.
63. Ogata K, Platt JL. Cardiac xenotransplantation: future and limitations. Cardiology 2004; 101:144-155. This article offers a discussion of the future of cardiac xenotransplantation, drawing lessons from investigations into antibody-mediated responses.
64. West LJ. Human ABO-incompatible organ transplantation as a clinical surrogate for discordant xenotransplantation? The role of accommodation vs. B cell tolerance. Xenotransplantation 2005; 12:366. This paper presents a brief discussion of the possibilities for ABO-incompatible organ transplantation to serve as a clinical surrogate for investigation of issues of importance to xenotransplantation.